Compound Shuganjieyu Capsule on CYP450 Enzyme Activity
Sign Up to like & getrecommendations! Published in 2022 at "BioMed Research International"
DOI: 10.1155/2022/3228738
Abstract: Objective To evaluate the potential drug-drug interactions of the Shuganjieyu capsule by establishing a Chronic Unpredictable Mild Stress (CUMS) depression model combined with the Cocktail probe substrate method. Methods The whole study was divided into… read more here.
Keywords: shuganjieyu capsule; cyp1a2 cyp2c19; group; capsule ... See more keywords
Abstract 3035: Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19 and CYP3A4 in patients with advanced solid tumors
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Research"
DOI: 10.1158/1538-7445.am2020-3035
Abstract: Background: Adavosertib (AD), a selective WEE1 inhibitor, may alter exposure to compounds metabolized by cytochromes P450 (CYP); this two-period open-label study (NCT03333824) assessed the effect of AD on pharmacokinetics (PK) of probe substrates for CYP1A2… read more here.
Keywords: solid tumors; cyp1a2 cyp2c19; cyp2c19 cyp3a4; substrates cyp1a2 ... See more keywords